Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 155 results found. Search for [ ANDAs ]

Results 1 to 21 of 155
BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore


PTI
January 23, 2021
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing


Niti Kiran
November 13, 2020
HDFC Securities top Diwali picks for making investments comprise Bharti Airtel,Infosys,Cadila Healthcare,ICICI Bank,United Spirits,Gujarat Gas among others


BusinessToday.In
October 20, 2020
India Stock Market Highlights Today: HCL Tech, followed by L&T, M&M, Tech Mahindra, Maruti, TCS, Asian Paints, Infosys and HDFC Bank were among the top gainers today. On the other hand, ONGC, Nestle India, SBI, ICICI Bank and IndusInd Bank were among the laggards


BusinessToday.In
September 25, 2020
India Stock Market News Updates Today: IndusInd Bank, M&M, TCS, Bajaj Finance, Bharti Airtel, Sun Pharma, Maruti, Tata Steel and Axis Bank were among the top gainers on Sensex pack. Kotak Bank wa the only loser.


BusinessToday.In
August 6, 2020
Following the result update, Cadila Healthcare shares fell 1.57% to the intraday low of Rs 389.55 on BSE against the earlier close of Rs 395.95. The stock also hit an intraday high of Rs 401.80 during today's session, after opening at Rs 396


PTI
July 19, 2020
The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others


PTI
July 19, 2020
The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others


PTI
July 18, 2020
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tabletsin strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement


PTI
July 6, 2020
\"Having said so, we believe FY2021 will have more uncertainties than ever before. Consequently, our overall performance may be quite volatile,\" Dr Reddy's Laboratories said


BusinessToday.In
June 4, 2020
Aurobindo Pharma share price opened with a gain of 3.91% today and later touched an all-time high of Rs 791, rising 5.38% on BSE against the last closing value of Rs 750.65


BusinessToday.In
New Delhi, June 3, 2020
In the fourth quarter ended March FY20, Aurobindo Pharma's revenue from operations was recorded at Rs 6,158.4 crore


BusinessToday.In
June 2, 2020
Following the update, Strides Pharma Science stock touched an intraday high of Rs 421, rising 5.36% against the last closing value of Rs 399.60 on BSE


BusinessToday.In
April 8, 2020
Share price of Cadilla closed 12% or 37 points higher at Rs 349.95 against previous close of Rs 312.50


BusinessToday.In
February 7, 2020
Share Market Update:  Britannia, SML Isuzu, CARE Ratings, Container Corporation Of India, Godfrey Phillips India, Sterling And Wilson Solar, Oberoi Realty, Procter & Gamble Health, Globus Spirits, Excel, Whirlpool among others will announce their Q3 results today


BusinessToday.In
November 21, 2019
Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year


Niti Kiran
November 14, 2019
An improvement in exports to the US, the key market for Indian drug manufacturers, drove the growth in overall exports from India


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PTI
August 9, 2019
Drug firm Cadila Healthcare on Friday reported a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PAGES 1 OF 8  12345